nerve molecule red w logo 3.jpg

The largest not-for-profit scientific network of Parkinson centers in North America

 

Parkinson Study Group has carried out cooperative therapeutic research since 1986, beginning with the NIH-sponsored DATATOP (Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism) clinical trial. Since then we have carried out more than 35 multi-center trials examining the symptomatic and neuroprotective effects of experimental interventions in Parkinson disease. The PSG has partnered with numerous pharmaceutical companies and the National Institutes of Health (NIH) in bringing new drugs for Parkinson disease to the market including pramipexole, entacapone, rotigotine and rasagiline.

Featured Event

March 5-6, 2016

4th Annual Shaping the Management of Parkinson’s Disease: debating the issues, discoveries and development

A Special Weekend CME Program with Parkinson Study Group Investigators
Register here: www.ccfcme.org/shapingPD16  /  Click here to download the event guide

 
Funding Resources img

Funding Resources

A collection of grants, awards and other funding available for Parkinson Disease research initiatives

Clinical Trials img

Clinical Trials

Clinical trials in progress, completed trials, PSG credentialed sites and other related resources

Study Kit img

Study Proposal Toolkit

Procedures, forms, sample projects and more, for those seeking to submit a study proposal


Upcoming Events & Deadlines